TickerFacts.

A business in context

IRWD research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-09-07 · 8010 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001104659-26-091987

  2. 8-K · Current report

    Report date 2026-08-06 · 0001104659-26-091625 · Items 2.02,9.01

  3. 4 · Ownership change

    Report date 2026-07-20 · 0001193125-26-312410

  4. 4 · Ownership change

    Report date 2026-07-07 · 0001193125-26-299749

  5. 8-K · Current report

    Report date 2026-06-16 · 0001104659-26-075730 · Items 5.02,5.07,9.01

  6. 4 · Ownership change

    Report date 2026-06-16 · 0001193125-26-274301

  7. 4 · Ownership change

    Report date 2026-06-16 · 0001193125-26-274292

  8. 4 · Ownership change

    Report date 2026-06-16 · 0001193125-26-274288

  9. 4 · Ownership change

    Report date 2026-06-16 · 0001193125-26-274283

  10. 4 · Ownership change

    Report date 2026-06-15 · 0001193125-26-274279

  11. 4 · Ownership change

    Report date 2026-06-16 · 0001193125-26-274275

  12. 8-K · Current report

    Report date 2026-06-15 · 0001104659-26-074023 · Items 8.01

  13. 8-K/A · Current report

    Report date 2026-05-08 · 0001104659-26-065140 · Items 5.02

  14. 8-K · Current report

    Report date 2026-05-08 · 0001104659-26-059814 · Items 5.02

  15. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001104659-26-057110

  16. 8-K · Current report

    Report date 2026-05-07 · 0001104659-26-056656 · Items 2.02,9.01

  17. DEF 14A · Proxy statement

    Report date 2026-06-16 · 0001104659-26-050325

  18. 8-K · Current report

    Report date 2026-03-10 · 0001104659-26-026123 · Items 8.01

  19. 10-K · Annual report

    Report date 2025-12-31 · 0001104659-26-020489

  20. 8-K · Current report

    Report date 2026-02-25 · 0001104659-26-019405 · Items 2.02,9.01

  21. 8-K · Current report

    Report date 2026-01-02 · 0001104659-26-000057 · Items 2.02,9.01

  22. 8-K · Current report

    Report date 2025-12-18 · 0001104659-25-123974 · Items 1.01,8.01,9.01

  23. 8-K · Current report

    Report date 2025-11-25 · 0001104659-25-116217 · Items 8.01

  24. 8-K · Current report

    Report date 2025-11-10 · 0001104659-25-108806 · Items 2.02,9.01

  25. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001104659-25-108795

  26. 8-K · Current report

    Report date 2025-10-07 · 0001104659-25-098523 · Items 5.02

  27. 8-K · Current report

    Report date 2025-08-29 · 0001104659-25-087008 · Items 8.01

  28. 10-Q · Quarterly report

    Report date 2025-06-30 · 0001558370-25-011050

  29. 8-K · Current report

    Report date 2025-08-07 · 0001104659-25-074972 · Items 2.02,9.01

  30. 8-K · Current report

    Report date 2025-07-03 · 0001104659-25-066986 · Items 4.01,9.01

  31. 8-K · Current report

    Report date 2025-06-10 · 0001104659-25-058883 · Items 5.07

  32. 8-K · Current report

    Report date 2025-05-28 · 0001104659-25-055958 · Items 3.01

  33. 10-Q · Quarterly report

    Report date 2025-03-31 · 0001558370-25-007406

  34. 8-K · Current report

    Report date 2025-05-07 · 0001104659-25-045310 · Items 2.02,9.01

  35. DEF 14A · Proxy statement

    Report date 2025-06-10 · 0001104659-25-040309

  36. 8-K · Current report

    Report date 2025-04-25 · 0001104659-25-039013 · Items 2.02,9.01

  37. 8-K · Current report

    Report date 2025-04-14 · 0001104659-25-034381 · Items 8.01,9.01

  38. 10-K · Annual report

    Report date 2024-12-31 · 0001558370-25-004072

  39. 8-K · Current report

    Report date 2025-03-21 · 0001104659-25-028766 · Items 3.01,7.01,9.01

  40. 8-K · Current report

    Report date 2025-02-27 · 0001104659-25-017774 · Items 2.02,9.01

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-09-07 · 2026 Q2: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 1 transaction rows1SGrant / award: 9 transaction rows9AExercise / conversion: 0 transaction rows0MTax / exercise payment: 0 transaction rows0FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

10 matching transaction rows.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-06-16
2026-06-17
Shepard JayA · Grant / award
Acquired
Class A Common Stock63481.00.0
2026-06-16
2026-06-17
Kessler Marla LA · Grant / award
Acquired
Class A Common Stock63481.00.0
2026-06-16
2026-06-17
Currie Mark GA · Grant / award
Acquired
Class A Common Stock63481.00.0
2026-06-16
2026-06-17
Duane Jon RA · Grant / award
Acquired
Class A Common Stock63481.00.0
2026-06-16
2026-06-17
DENNER ALEXANDER JA · Grant / award
Acquired
Class A Common Stock63481.00.0
2026-06-16
2026-06-17
McHugh JulieS · Sale
Disposed
Class A Common Stock21571.03.73
2026-06-16
2026-06-17
McHugh JulieA · Grant / award
Acquired
Class A Common Stock63481.00.0
2026-06-16
2026-06-17
Moukheibir CatherineA · Grant / award
Acquired
Class A Common Stock63481.00.0
2026-06-15
2026-06-17
DENNER ALEXANDER JA · Grant / award
Acquired
Class A Common Stock4065.00.0
2026-05-19
2026-05-21
Silver RonaldA · Grant / award
Acquired
Common Stock25000.00.0

Identity & relationships

Wikidata structured data · retrieved 2026-09-07 · 1611 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001446847IRONWOOD PHARMACEUTICALS INC

No parent relationship is available in this import; this is not proof of independence.

Legal Entity Identifier
549300PC8MR6QHH6P296
GLEIF legal name
IRONWOOD PHARMACEUTICALS, INC.
Entity / LEI registration status
ACTIVE / LAPSED
Reference data updated
2025-01-04T13:30:03Z

direct-parent: no parent LEI supplied

ultimate-parent: no parent LEI supplied

GLEIF legal entity reference data · retrieved 2026-09-07 · 1177 checked identities; 0 unavailable records

Search names and former names

View Wikidata identity and references ↗

  • Ironwood Pharmaceuticals · alias · wikidata
  • Ironwood Pharmaceuticals (United States) · alias · wikidata
Explore headquarters map ↗

Revenue in constant purchasing power

USD revenue expressed in 2026-07 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

Year endedReported USD revenueCPI-adjusted USD revenue
2024-12-31$351.41M$374.06M
2023-12-31$442.74M$485.16M
2022-12-31$410.60M$468.41M
2021-12-31$413.75M$509.78M
2020-12-31$389.52M$502.56M
2019-12-31$428.41M$559.52M
2018-12-31$346.64M$460.94M
2017-12-31$298.28M$406.32M

Bureau of Labor Statistics · retrieved 2026-09-07 · 9 selected series; gaps remain missing

Explore the CPI history ↗